Floatz logo

2-TRIFLUOROMETHYL-9-(3-(4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)PROPYLIDENE)THIOXANTHENE

Antipsychotic Agents

Taichung Veterans General HospitalSmall moleculePhase 4 / ApprovedDormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Antipsychotic Agents cohort.

Asset / SponsorPhaseRating
Paliperidone Palmitate 3-Month Formulation
Centre for Addiction and Mental Health
Phase 4BB
Olanzapine
Centre for Addiction and Mental Health
Phase 4BB
Risperdal
Centre for Addiction and Mental Health
Phase 4BB
ly03010
Luye Pharma Group Ltd.
Phase 1CCC

Same molecule, other indications

2-TRIFLUOROMETHYL-9-(3-(4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)PROPYLIDENE)THIOXANTHENE is also rated in:

FlupentixolDormant
B
Indicative ·
62 / 100
View asset →
central nervous system disorderDormant
B
Indicative ·
62 / 100
View asset →
OlanzapineDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →